N Engl J Med 2016 Feb 25
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
Related Questions
New answer by Medical Oncologist at University of Pittsburgh Magee Womens Hospital (January 15, 2019)
The answer to this question is definitively NO.Two large, definitive studies (ICON-7 and GOG218 – including over 3400 patient combined) evaluated the impact of adjuvant ...
When do you choose dose-dense chemotherapy v. q3 week therapy in advanced epithelial ovarian cancer?
New answer by Medical Oncologist at Harvard Medical School (July 15, 2019)
In our recent OGR, we suggested an approach to deciding which patients might be appropriate for considering the dose-dense regimen in the first line setting (Figure 2). ...
New answer by Medical Oncologist at University of Pittsburgh Magee Womens Hospital (January 3, 2021)
This is a great question and there is a lovely discussion above. I think the key summary point is that the weekly carbo-paclitaxel (Mito-7) regimen is clearly not inferior, an...